瓦尔酸联合处方对临床实践中的克洛沙药理动学的影响
Robert James Flanagan1, Stephen John Obee1, Alice Hyun Min Kim2
1From the Department of Precision Medicine, Networked Services, Bessemer Wing, King's College Hospital NHS Foundation Trust, London, England.
Journal of clinical psychopharmacology
|January 21, 2025
概括
酸可能会增加非吸烟者的克洛扎水平,可能会增加毒性. 由于复杂的药理动力学相互作用,这种组合需要在所有患者中仔细考虑.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 临床治疗学 临床治疗学
背景情况:
- 甲酸盐通常与克洛扎宾联合处方,用于预防发作和治疗耐药精神分裂症.
- 氨酸对克洛扎代谢和相关副作用的影响尚不清楚.
研究的目的:
- 为了研究氨酸联合处方对克洛扎血度和N-desmethylclozapine (诺克洛扎) 水平的影响.
- 在吸烟状态和性别方面检查这些影响.
主要方法:
- 从1996年至2017年对克洛扎治疗药物监测数据的回顾性分析.
- 血克洛沙宾和诺克洛沙宾度的比较,对照组与同时服用瓦尔酸盐的患者进行比较.
- 分析按吸烟状况 (吸烟者与非吸烟者) 和性别分层.
主要成果:
- 在非吸烟者中,valproate联合处方增加了非吸烟者的平均血克洛沙宾的22.5%,表明中度的代谢抑制.
- 在吸烟者中,没有观察到氨酸对血克洛沙的显著影响.
- 瓦尔酸盐显著降低了血诺克洛zapine,并在所有治疗组中增加了克洛zapine与诺克洛zapine的比率,显示出剂量反应关系.
结论:
- 同时服用瓦尔酸盐会使克洛扎的药理动力学复杂化.
- 由于可能增加克洛沙平的毒性,因此需要对所有患者的这种组合进行重新评估.
- 建议在结合瓦尔酸盐和克洛沙时谨慎使用,无论患者的人口统计学情况如何.
相关概念视频
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
78
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
78
01:26Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
114
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
114
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
224
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
224
01:09Hepatic Drug Clearance: Effect of Protein Binding
145
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
145
01:21Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K